Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 200 | 200 | 200 | 200 | 67 |
| Gross Profit | 200 | 200 | 200 | 200 | 67 |
| Operating Expenses | 18,833 | 16,617 | 14,409 | 13,048 | 27,993 |
| Operating Income | -18,633 | -16,417 | -14,209 | -12,848 | -27,926 |
| Other Income | -5,837 | 3,173 | 13,407 | 2,124 | -11,082 |
| Pre-tax Income | -24,470 | -13,244 | -802 | -10,724 | -39,008 |
| Net Income Continuous | -24,470 | -13,244 | -802 | -10,724 | -39,008 |
| Net Income | $-24,470 | $-13,244 | $-802 | $-10,724 | $-39,008 |
| EPS Basic Total Ops | -47.98 | -22.49 | -1.50 | -23.99 | -97.45 |
| EPS Basic Continuous Ops | -48.51 | -22.38 | -1.77 | -23.92 | -96.80 |
| EPS Diluted Total Ops | -47.98 | -22.49 | -1.50 | -23.99 | -97.45 |
| EPS Diluted Continuous Ops | -48.51 | -22.38 | -1.77 | -23.92 | -96.80 |
| EBITDA(a) | $-18,515 | $-16,321 | $-14,132 | $-12,790 | $-27,889 |